Skip to content

Author

S. V. D. van de Graaf

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Combination pharmacotherapy for MASH: Potential synergistic approaches.

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent and severe liver disease globally, encompassing a spectrum from isolated steatosis to metabolic dysfunction-associated steatohepatitis (MASH), the progressive inflammatory form that can lead to fibrosis, cirrhosis, and hepatocellular...

Dana A. Meije, A. Holleboom, S. V. D. van de Graaf · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.